These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

222 related items for PubMed ID: 26986483

  • 1. Immunological Characterization of Plant-Based HIV-1 Gag/Dgp41 Virus-Like Particles.
    Kessans SA, Linhart MD, Meador LR, Kilbourne J, Hogue BG, Fromme P, Matoba N, Mor TS.
    PLoS One; 2016; 11(3):e0151842. PubMed ID: 26986483
    [Abstract] [Full Text] [Related]

  • 2. A heterologous prime-boosting strategy with replicating Vaccinia virus vectors and plant-produced HIV-1 Gag/dgp41 virus-like particles.
    Meador LR, Kessans SA, Kilbourne J, Kibler KV, Pantaleo G, Roderiguez ME, Blattman JN, Jacobs BL, Mor TS.
    Virology; 2017 Jul; 507():242-256. PubMed ID: 28458036
    [Abstract] [Full Text] [Related]

  • 3. Biological and biochemical characterization of HIV-1 Gag/dgp41 virus-like particles expressed in Nicotiana benthamiana.
    Kessans SA, Linhart MD, Matoba N, Mor T.
    Plant Biotechnol J; 2013 Aug; 11(6):681-90. PubMed ID: 23506331
    [Abstract] [Full Text] [Related]

  • 4. A Novel MVA-Based HIV Vaccine Candidate (MVA-gp145-GPN) Co-Expressing Clade C Membrane-Bound Trimeric gp145 Env and Gag-Induced Virus-Like Particles (VLPs) Triggered Broad and Multifunctional HIV-1-Specific T Cell and Antibody Responses.
    Perdiguero B, Sánchez-Corzo C, Sorzano COS, Saiz L, Mediavilla P, Esteban M, Gómez CE.
    Viruses; 2019 Feb 16; 11(2):. PubMed ID: 30781504
    [Abstract] [Full Text] [Related]

  • 5. Bovine papillomavirus-like particles presenting conserved epitopes from membrane-proximal external region of HIV-1 gp41 induced mucosal and systemic antibodies.
    Zhai Y, Zhong Z, Zariffard M, Spear GT, Qiao L.
    Vaccine; 2013 Nov 04; 31(46):5422-9. PubMed ID: 24055348
    [Abstract] [Full Text] [Related]

  • 6. Virological and immunological characterization of novel NYVAC-based HIV/AIDS vaccine candidates expressing clade C trimeric soluble gp140(ZM96) and Gag(ZM96)-Pol-Nef(CN54) as virus-like particles.
    Perdiguero B, Gómez CE, Cepeda V, Sánchez-Sampedro L, García-Arriaza J, Mejías-Pérez E, Jiménez V, Sánchez C, Sorzano CÓ, Oliveros JC, Delaloye J, Roger T, Calandra T, Asbach B, Wagner R, Kibler KV, Jacobs BL, Pantaleo G, Esteban M.
    J Virol; 2015 Jan 15; 89(2):970-88. PubMed ID: 25355891
    [Abstract] [Full Text] [Related]

  • 7. Humoral immune responses by prime-boost heterologous route immunizations with CTB-MPR(649-684), a mucosal subunit HIV/AIDS vaccine candidate.
    Matoba N, Geyer BC, Kilbourne J, Alfsen A, Bomsel M, Mor TS.
    Vaccine; 2006 Jun 05; 24(23):5047-55. PubMed ID: 16621185
    [Abstract] [Full Text] [Related]

  • 8. The improved antibody response against HIV-1 after a vaccination based on intrastructural help is complemented by functional CD8+ T cell responses.
    Storcksdieck genannt Bonsmann M, Niezold T, Hannaman D, Überla K, Tenbusch M.
    Vaccine; 2016 Apr 04; 34(15):1744-51. PubMed ID: 26945099
    [Abstract] [Full Text] [Related]

  • 9. Biochemical and immunological characterization of the plant-derived candidate human immunodeficiency virus type 1 mucosal vaccine CTB-MPR.
    Matoba N, Kajiura H, Cherni I, Doran JD, Bomsel M, Fujiyama K, Mor TS.
    Plant Biotechnol J; 2009 Feb 04; 7(2):129-45. PubMed ID: 19037902
    [Abstract] [Full Text] [Related]

  • 10. Multiple tandem copies of conserved gp41 epitopes incorporated in gag virus-like particles elicit systemic and mucosal antibodies in an optimized heterologous vector delivery regimen.
    Jain S, Patrick AJ, Rosenthal KL.
    Vaccine; 2010 Oct 08; 28(43):7070-80. PubMed ID: 20723627
    [Abstract] [Full Text] [Related]

  • 11. Toll-like receptor 3 adjuvant in combination with virus-like particles elicit a humoral response against HIV.
    Poteet E, Lewis P, Chen C, Ho SO, Do T, Chiang S, Labranche C, Montefiori D, Fujii G, Yao Q.
    Vaccine; 2016 Nov 21; 34(48):5886-5894. PubMed ID: 27997339
    [Abstract] [Full Text] [Related]

  • 12. Incorporation of Ebola glycoprotein into HIV particles facilitates dendritic cell and macrophage targeting and enhances HIV-specific immune responses.
    Ao Z, Wang L, Mendoza EJ, Cheng K, Zhu W, Cohen EA, Fowke K, Qiu X, Kobinger G, Yao X.
    PLoS One; 2019 Nov 21; 14(5):e0216949. PubMed ID: 31100082
    [Abstract] [Full Text] [Related]

  • 13. In vivo electroporation in DNA-VLP prime-boost preferentially enhances HIV-1 envelope-specific IgG2a, neutralizing antibody and CD8 T cell responses.
    Huang X, Zhu Q, Huang X, Yang L, Song Y, Zhu P, Zhou P.
    Vaccine; 2017 Apr 11; 35(16):2042-2051. PubMed ID: 28318765
    [Abstract] [Full Text] [Related]

  • 14. Hemagglutinin and neuraminidase containing virus-like particles produced in HEK-293 suspension culture: An effective influenza vaccine candidate.
    Venereo-Sanchez A, Gilbert R, Simoneau M, Caron A, Chahal P, Chen W, Ansorge S, Li X, Henry O, Kamen A.
    Vaccine; 2016 Jun 17; 34(29):3371-80. PubMed ID: 27155499
    [Abstract] [Full Text] [Related]

  • 15. Construction and Production of HIV-VLP Harboring MPER-V3 for Potential Vaccine Study.
    Tohidi F, Sadat SM, Bolhassani A, Yaghobi R.
    Curr HIV Res; 2017 Jun 17; 15(6):434-439. PubMed ID: 29046160
    [Abstract] [Full Text] [Related]

  • 16. Analysis of the human immunodeficiency virus type 1 gp41 membrane proximal external region arrayed on hepatitis B surface antigen particles.
    Phogat S, Svehla K, Tang M, Spadaccini A, Muller J, Mascola J, Berkower I, Wyatt R.
    Virology; 2008 Mar 30; 373(1):72-84. PubMed ID: 18155743
    [Abstract] [Full Text] [Related]

  • 17. Effect of HIV-1 envelope cytoplasmic tail on adenovirus primed virus encoded virus-like particle immunizations.
    Andersson AC, Ragonnaud E, Seaton KE, Sawant S, Folgori A, Colloca S, Labranche C, Montefiori DC, Tomaras GD, Holst PJ.
    Vaccine; 2016 Oct 17; 34(44):5344-5351. PubMed ID: 27633665
    [Abstract] [Full Text] [Related]

  • 18. Targeting antibody responses to the membrane proximal external region of the envelope glycoprotein of human immunodeficiency virus.
    Kamdem Toukam D, Tenbusch M, Stang A, Temchura V, Storcksdieck Genannt Bonsmann M, Grewe B, Koch S, Meyerhans A, Nchinda G, Kaptue L, Uberla K.
    PLoS One; 2012 Oct 17; 7(5):e38068. PubMed ID: 22666448
    [Abstract] [Full Text] [Related]

  • 19. Virus-like vaccines against HIV/SIV synergize with a subdominant antigen T cell vaccine.
    Schwerdtfeger M, Andersson AC, Neukirch L, Holst PJ.
    J Transl Med; 2019 May 24; 17(1):175. PubMed ID: 31126293
    [Abstract] [Full Text] [Related]

  • 20. Use of the piggyBac transposon to create HIV-1 gag transgenic insect cell lines for continuous VLP production.
    Lynch AG, Tanzer F, Fraser MJ, Shephard EG, Williamson AL, Rybicki EP.
    BMC Biotechnol; 2010 Mar 31; 10():30. PubMed ID: 20356379
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 12.